U.S. meeting nears on risks of Glaxo diabetes drug (Reuters)

[Mgtrben news]

Reuters - A heated three-year safety debate about a GlaxoSmithKline Plc diabetes pill reaches a climax this week as opponents and backers face off at a U.S. meeting that will help decide the drug's fate.

Source (http://us.rd.*****.com/dailynews/rss/topstories/*http://news.*****.com/s/nm/20100713/bs_nm/us_glaxo_avandia)